Skip to content

Safety and feasibility study of community cooperation based online TFCBT for PTSD

Safety and feasibility pilot study of community cooperation based online TFCBT for PTSD - Safety and feasibility pilot study of online TFCBT for PTSD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045770
Enrollment
7
Registered
2021-10-20
Start date
2021-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder (PTSD)

Interventions

Online TFCBT for sexual assault victims with PTSD

Sponsors

Musashino University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subject is consulting at the community rape crisis center, and the rape crisis center staff has agreed to cooperate with this study. 2. Diagnosed with PTSD by the community psychiatric medical institution. 3. The psychiatrist has approved the subject's participation in this study, and continuation of their once or if necessary, more than once a month consultation throughout the period of participation. 4. During the course of the psychotherapy, the subject and psychiatrist have agreed that the therapist, assessor, rape crisis center staff, etc., may inquiry them regarding the treatment, prescription, etc. 5. According to CAPS-5, the subject has been assessed with PTSD or a condition equivalent to PTSD (adjustment disorder, etc.) in relation to the concerned traumatic experience. 6. Is able to visit the community rape crisis center once a week. 7. Is able to use an online device and communicate in Japanese adequately. 8. Has no comorbid diagnosis of schizophrenia and other related disorders. 9. Has no comorbid physical disorder in which would interfere with the treatment. 10. During the assessment, there was no presence of psychological symptoms (manic state of bipolar disorder and extreme emotional instability, alcohol/substance abuse/dependence, severe depressive symptoms, self-harming behaviors, suicidal attempts, etc.) requiring other treatment/s which should be prioritized. 11. Has no clinical history of alcohol/substance dependence or abuse within the past 6 months. 12. Has no clinical history of suicidal attempt and serious self-harming behaviors (manipulative self-harm such as severe cut wounds, unconsciousness or overdose, etc.) within the past 6 months. 13. Has no changes in the prescription of antidepressants and antipsychotic medications for the past month, and currently has no plans in changing the prescription during the course of the treatment. 14. Not receiving any other psychotherapy other than supportive psychotherapy.

Exclusion criteria

Exclusion criteria: Other reasons in which the researchers determined the subject as inappropriate for this study

Design outcomes

Primary

MeasureTime frame
1.Dropout rate 2.Occurrence of adverse event

Secondary

MeasureTime frame
1.PTSD Checklist for DSM-5(PCL-5) 2.Beck Depression Inventory -II(BDI -II) 3.Dissociative Experiences Scale(DES) 4.Posttraumatic Cognitions Inventory(JPTCI) 5. Clinician-Administered PTSD Scale for DSM-5(CAPS-5) 6. Mini International Neuropsychiatric Interview(M.I.N.I.)

Countries

Japan

Contacts

Public ContactRieko Konno

Musashino University Department of Human Sciences

rkonno@musashino-u.ac.jp03-5530-7333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026